Dr Guangzu Zhao ~ Postdoctoral Research Fellow
Australian Institute of Tropical Health & Medicine
- About
-
- Research Disciplines
- Socio-Economic Objectives
- Publications
-
These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.
- Journal Articles
-
- Cobos C, Bansal P, Wilson D, Jones L, Zhao G, Field M, Eichenberger R, Pickering D, Ryan R, Ratnatunga C, Miles J, Ruscher R, Giacomin P, Navarro S, Loukas A and Daly N (2022) Peptides derived from hookworm anti-inflammatory proteins suppress inducible colitis in mice and inflammatory cytokine production by human cells. Frontiers in Medicine, 9.
- Ritmejeryte E, Ryan R, Byatt B, Peck Y, Yeshi K, Daly N, Zhao G, Crayn D, Loukas A, Pyne S, Ruscher R and Wangchuk P (2022) Anti-inflammatory properties of novel galloyl glucosides isolated from the Australian tropical plant Uromyrtus metrosideros. Chemico-Biological Interactions, 368.
- Du Q, Huang Y, Bajpai A, Frosig- Jorgensen M, Zhao G and Craik D (2020) Evaluation of the in vivo aphrodisiac activity of a cyclotide extract from Hybanthus enneaspermus. Journal of Natural Products, 83 (12). pp. 3736-3743
- Skwarczynski M, Zhao G, Boer J, Ozberk V, Azuar A, Cruz J, Giddam A, Khalil Z, Pandey M, Shibu M, Hussein W, Nevagi R, Batzloff M, Wells J, Capon R, Plebanski M, Good M and Toth I (2020) Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines. Science Advances, 6 (5).
- Zhao G, Chandrudu S, Skwarczynski M and Toth I (2017) The application of self-assembled nanostructures in peptide-based subunit vaccine development. European Polymer Journal, 93. pp. 670-681
- Other research outputs
-
- Zhao G, Azuar A, Toth I and Skwarczynski M (2021) A potent vaccine delivery system. Bio-protocol, 11 (7). p. e3973
- Current Funding
-
Current and recent Research Funding to JCU is shown by funding source and project.
Validate - Pump-Priming Grant
Evaluation of BCG?BCG1419c:ESAT6-PE25SS in immunocompetent and immunocompromised mouse models of TB
- Indicative Funding
- $98,016 over 1 year
- Summary
- Tuberculosis (TB) is a major public health concern that causes more than 1.5 million deaths each year. Vaccination is considered one of the most effective ways to eliminate TB. However, the only licensed TB vaccine, called BCG, provides limited protection against the disease in adults and can cause dangerous side effects in people with weaker immune systems. This project aims to investigate whether a new vaccine candidate can induce a stronger immune response and better protection against tuberculosis in mice with normal immune systems and is well-tolerated in mice with compromised immune systems, when compared with the original BCG vaccine.
- Investigators
- Ana Maria Valencia Hernandez, Socorro Miranda-Hernandez, Guangzu Zhao, Andreas Kupz and Mario Alberto Flores-Valdez (Australian Institute of Tropical Health & Medicine and CIATEJ)
- Keywords
- Mycobacterium Tuberculosis; Vaccine Development; Immunology; Bcg; Infectious deseases
- Collaboration
-
The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.- 5+ collaborations
- 4 collaborations
- 3 collaborations
- 2 collaborations
- 1 collaboration
- Indicates the Tropics (Torrid Zone)
Connect with me
Share my profile:
jcu.me/guangzu.zhao
Share my profile:
jcu.me/guangzu.zhao
jcu.me/guangzu.zhao
- Location
- Find me on…
-
My research areas
Similar to me
-
Dr Roland RuscherAustralian Institute of Tropical Health & Medicine
-
Dr Rachael RyanAustralian Institute of Tropical Health & Medicine
-
A/Prof Severine NavarroVeterinary Science
-
Dr Phurpa WangchukBiomedical Sciences and Molecular Biology
-
Prof Norelle DalyAustralian Institute of Tropical Health & Medicine